I-CAS 204656-20-2 ILiraglutide yaseTshayina intengiso egqwesileyo yefektri ngokuthe ngqo uKhuseleko oluPhezulu loKhuseleko oluPhezulu Ukuhanjiswa okuphezulu Umgangatho ofanelekileyo ixabiso eliphakamileyo lamaxabiso aphezulu ukwaneliseka Ukuhanjiswa okukhawulezayo
Ingcaciso yeMveliso
I-Liraglutide yi-GLP-1 (1-37) iguqulwe e-Ly: iqela le-amino li-acylated kunye ne-(N-hexadecanoyl) glutam- -yl moiety ebophelela ngokungekho ngqiqweni kodwa ngokungqongqo kwi-albumin ye-serum yomntu. (Kwakhona, i-Lys is conservatively replaced with Arg.) Olu tshintsho lubonelela ngeserum eyandisiweyo kakhulu i-t1?2 ye-10 ukuya kwiiyure ezili-15 emva kolawulo lwe-sc(0.6–1.8 mg), ivumela idosi kanye ngemini.Liraglutide (Victoza, Novo Nordisk) ilindele ukwamkelwa yi-FDA, EMEA, kunye neKoˉ roˉ -shoˉ (eJapan).
ividiyo yemveliso
Isicelo seMveliso
I-Liraglutide luhlobo olutsha lwechiza le-hypoglycemic eyenza i-AMP-activated protein kinase ngaloo ndlela ikhulise uvakalelo lwe-insulin. Ayinayo nje impembelelo enkulu ye-hypoglycemic, kodwa inemisebenzi yokulahleka kwesisindo, ukunciphisa uxinzelelo lwegazi, kunye nokuphuculwa kweprofayili ye-lipid yegazi.
I-Liraglutide, i-glucagon yomntu efana ne-peptide-1 (GLP-1) ye-receptor agonist, iyacotha ukuphuma kwesisu, inyusa ukuhlutha, kwaye iyanciphisa ukutya kwesigulana, ngelixa inciphisa umnqweno wengqondo wokutya kunye nokuvumela umzimba ukuba Ukonyuka kwenkcitho yamandla kudlala indima kubunzima. ilahleko; ikhusela isibindi ekuveliseni i-glucose eninzi kwaye ikhuthaza i-pancreas ukuvelisa i-insulin eninzi ukunciphisa iswekile yegazi; Ukongeza, i-liraglutide ikwanezibonelelo zentliziyo kunye nokukhuselwa kwezintso.
ukucaciswa kwemveliso
Igama eliqhelekileyo | ILiraglutide |
Inombolo yeCAS | 204656-20-2 |
Ifomula yeemolekyuli | C172H265N43O51 |
Ubunzima beMolekyuli | 3751.20000 |
PSA | 1513.76000 |
LogP | 6.12960 |
EINECS | 810-818-7 |